Results 141 to 150 of about 15,487 (155)

Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicity

Toxicology, 2012
Marinho At, Nadia Grilo, Umbelina Caixàs   +2 more
exaly  

Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production

Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
Alejandro Arenas-Pinto, Kees Brinkman, Remco Franssen   +2 more
exaly  

HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS

Pharmacological Research, 2002
Jos Beijnen, Jan W Mulder, Agnes I Veldkamp   +2 more
exaly  

Nevirapine

Reactions Weekly, 1999
  +4 more sources

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Lancet, The, 2004
Frank Van Leth, F W Wit, F Mulcahy
exaly  

Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells

Gynecologic Oncology, 2008
Alexandros Rodolakis
exaly  

Case-Control Exploration of Relationships Between Early Rash or Liver Toxicity and Plasma Concentrations of Nevirapine and Primary Metabolites

HIV Clinical Trials, 2007
David B Hall, Thomas R Macgregor
exaly  

Efavirenz and Nevirapine in HIV-1 Infection

Clinical Pharmacokinetics, 2012
Karen Dahri, , Ensom Mary H H
exaly  

Nevirapine

Reactions Weekly, 2001
openaire   +1 more source

Nevirapine

Reactions Weekly, 2008
openaire   +2 more sources